Business Wire

Abiomed Expands Product Portfolio with Acquisition of Cardiopulmonary Support Technology (ECMO) to Improve Outcomes for Patients

DANVERS, Mass.--(BUSINESS WIRE)--Abiomed (NASDAQ: ABMD), maker of the Impella heart pump, has acquired Breethe, developer of a novel extracorporeal membrane oxygenation (ECMO) system that will ...
Business Wire

PROTECT III Study Shows Placing Impella Prior to High-Risk PCI is Associated with Lower Mortality Compared to Bailout PCI

DANVERS, Mass.--(BUSINESS WIRE)--Data from more than 1,000 patients presented during the virtual 2020 Society for Cardiovascular Angiography & Interventions (SCAI) Scientific Sessions demonstrates ...
Yahoo! Sports

PROTECT III Presented at TCT 2019 – Clinical Data Demonstrates Protected PCI with Impella is Associated with Improved Outcomes

Abiomed (NASDAQ: ABMD) announces the results of PROTECT III, the ongoing, prospective, single-arm FDA post-approval study for the PMA approval of Impella 2.5 and Impella CP in high-risk PCI. PROTECT ...
TCTMD

Impella in High-risk Nonemergent PCI: Early Differences Disappear by 1 Year

Compared with no added support, use of the Impella percutaneous left ventricular assist device (Abiomed) in patients undergoing high-risk nonemergent PCI is associated with more periprocedural MI ...
TCTMD

Prioritizing Impella Support May Boost Cardiogenic Shock Survival, Pilot Study Suggests

WASHINGTON, DC—A protocol focusing on early use of the Impella ventricular support device (Abiomed) in patients with acute MI complicated by cardiogenic shock may help lower the stubbornly high ...
Nasdaq

First 1,000 Patients Treated with Impella 5.5 with SmartAssist, a Heart Pump Designed for Surgeons

In October 2019, the first U.S. patients were successfully treated by cardiac surgeons at Cleveland Clinic, Hackensack Meridian Health and Cedars-Sinai Medical Center. Since then, more than 120 ...
Nasdaq

World’s First Patient Implanted with Impella BTR Minimally Invasive Heart Pump

DANVERS, Mass.--(BUSINESS WIRE)-- Abiomed (Nasdaq: ABMD) announces the first patient in the world has been successfully implanted with Impella Bridge-to-Recovery (BTR) as part of the heart pump’s U.S.
Healio

Indications for Hemodynamic Support in the Cath Lab

As physicians increasingly treat patients with more complex CAD, the use of hemodynamic support in the cath lab may become commonplace. However, the availability of multiple systems, including the ...
MedPage Today

CardioBrief: Impella No Better Than IABP in Cardiogenic Shock

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window WASHINGTON -- A ...
Medscape

Impella-Pump Bleeding, Mortality 'Signals' in MI-Shock and High-Risk PCI

PHILADELPHIA — Interventional cardiology has taken quite a shine to Impella ventricular assist pumps (Abiomed) for cardiogenic shock (CS) and to support high-risk procedures, but two new observational ...
dailyfreeman.com

FDA Grants Highest Level of Approval to the Next Generation of Impella RP to Treat Right Heart Failure

Abiomed’s (NASDAQ: ABMD) newest right heart pump, the Impella RP with SmartAssist, has received U.S. Food and Drug Administration (FDA) pre-market approval (PMA) as safe and effective to treat acute ...
Medscape

Class I Recall of All Impella Left-Sided Heart Pumps

Abiomed is recalling all Impella left-sided blood pumps in the US over a potential safety issue when used in patients with a transcatheter aortic valve replacement (TAVR) stent ― something that is not ...